Galapagos NV
GLPG
#4631
Rank
โ‚น186.04 B
Marketcap
โ‚น2,823
Share price
-1.83%
Change (1 day)
23.72%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -โ‚น34.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น30.77. In 2024 the company made an earnings per share (EPS) of โ‚น105.77 a decrease over its 2023 EPS that were of โ‚น322.03.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น34.67-132.78%
2024โ‚น105.77-67.16%
2023โ‚น322.03-199.64%
2022-โ‚น323.1999.03%
2021-โ‚น162.38-68.98%
2020-โ‚น523.51-298.06%
2019โ‚น264.32-554.64%
2018-โ‚น58.14-77.18%
2017-โ‚น254.79-326.21%
2016โ‚น112.64-134.19%
2015-โ‚น329.43-371.34%
2014โ‚น121.41-445.98%
2013-โ‚น35.0932.88%
2012-โ‚น26.41-82.07%
2011-โ‚น147.32-817.9%
2010โ‚น20.5212.73%
2009โ‚น18.20-120.79%
2008-โ‚น87.54-37.67%
2007-โ‚น140.4639.64%
2006-โ‚น100.5928.17%
2005-โ‚น78.486.25%
2004-โ‚น73.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
โ‚น275.43-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น947.38-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น336.29-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น122.68-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-โ‚น55.36 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น731.18-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น57.17-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น326.33-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น689.14-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA